2 Stocks in the Trading Spotlight Ahead of Earnings

Life Technologies Corporation (NASDAQ:LIFE) will unveil its latest earnings on Tuesday, February 7, 2012. The average estimate of analysts is for net income of $1.03 per share, a rise of 14.4% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.04. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. Analysts are projecting profit to rise by 4.2% versus last year to $3.70.

Last quarter, the company came in at profit of 94 cents per share against a mean estimate of net income of 88 cents per share, beating estimates after missing them in the previous quarter. In the second quarter, it missed forecasts by 5 cents. Analysts are projecting a rise of 3.6% in revenue from the year-earlier quarter to $967.7 million.

Competitors to Watch: Techne Corporation (NASDAQ:TECH), Qiagen NV (NASDAQ:QGEN), Affymetrix, Inc. (NASDAQ:AFFX), Sigma-Aldrich Corporation (NASDAQ:SIAL), Thermo Fisher Scientific Inc. (NYSE:TMO), Strategic Diagnostics Inc. (NASDAQ:SDIX), Agilent Technologies Inc. (NYSE:A), Bio-Rad Laboratories, Inc. (NYSE:BIO), PerkinElmer, Inc. (NYSE:PKI), and Johnson & Johnson (NYSE:JNJ).

Steris Corp (NYSE:STE) will unveil its latest earnings on Tuesday, February 7, 2012. The average estimate of analysts is for net income of 61 cents per share, a rise of 7% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 63 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 61 cents during the last month. Analysts are projecting profit to rise by 1.4% versus last year to $2.22.

The company showed profit of 46 cents per share versus a mean estimate of net income of last quarter. This marks the fourth month of falling short of estimates. On average, analysts predict $363.4 million in revenue this quarter, a rise of 10.7% from the year ago quarter. Analysts are forecasting total revenue of $1.41 billion for the year, a rise of 16.5% from last year’s revenue of $1.21 billion.

Competitors to Watch: Stryker Corporation (NYSE:SYK), Cantel Medical Corp. (NYSE:CMN), Medical Action Industries (NASDAQ:MDCI), Kinetic Concepts, Inc. (NYSE:KCI), Invacare Corporation (NYSE:IVC), Becton, Dickinson and Co. (NYSE:BDX), Hill-Rom Holdings, Inc. (NYSE:HRC), Thermo Fisher Scientific Inc. (NYSE:TMO), and Winner Medical Group, Inc (NASDAQ:WWIN).

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com

More from The Cheat Sheet